| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
2 International Blood Group Reference Laboratory, Southmead Road, Bristol BS10 5NO, UK
Correspondence
John Collinge
j.collinge{at}prion.ucl.ac.uk
Prion diseases involve conversion of host-encoded cellular prion protein (PrPC) to a disease-related isoform (PrPSc). Using recombinant human 
-PrP, a panel of monoclonal antibodies was produced that efficiently immunoprecipitated native PrPSc and recognized epitopes between residues 93–105, indicating for the first time that this region is exposed in both human vCJD and mouse RML prions. In contrast, monoclonal antibodies raised to human 
-PrP were more efficient in immunoprecipitating PrPC than PrPSc, and some of them could also distinguish between different PrP glycoforms. Using these monoclonal antibodies, the physical association of PrP glycoforms was studied in normal brain and in the brains of humans and mice with prion disease. It was shown that while PrPC glycoforms can be selectively immunoprecipitated, the differentially glycosylated molecules of native PrPSc are closely associated and always immunoprecipitate together. Furthermore, the ratio of glycoforms comprising immunoprecipitated native PrPSc from diverse prion strains was similar to those observed on denaturing Western blots. These studies are consistent with the view that the proportion of each glycoform incorporated into PrPSc is probably controlled in a strain-specific manner and that each PrPSc particle contains a mixture of glycoforms.
This article has been cited by other articles:
|
|
 |
|
  J. Collinge and A. R. Clarke A General Model of Prion Strains and Their Pathogenicity Science, November 9, 2007; 318(5852): 930 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Owen, H. C. Rees, B. C. Maddison, L. A. Terry, L. Thorne, R. Jackman, G. C. Whitelam, and K. C. Gough Molecular Profiling of Ovine Prion Diseases by Using Thermolysin-Resistant PrPSc and Endogenous C2 PrP Fragments J. Virol., October 1, 2007; 81(19): 10532 - 10539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lewis, M. H. Tattum, S. Jones, D. Bhelt, M. Batchelor, A. R. Clarke, J. Collinge, and G. S. Jackson Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J. Gen. Virol., August 1, 2006; 87(Pt 8): 2443 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Novitskaya, N. Makarava, A. Bellon, O. V. Bocharova, I. B. Bronstein, R. A. Williamson, and I. V. Baskakov Probing the Conformation of the Prion Protein within a Single Amyloid Fibril Using a Novel Immunoconformational Assay J. Biol. Chem., June 2, 2006; 281(22): 15536 - 15545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. F. Wadsworth, S. Joiner, J. M. Linehan, S. Cooper, C. Powell, G. Mallinson, J. Buckell, I. Gowland, E. A. Asante, H. Budka, et al. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein Brain, June 1, 2006; 129(6): 1557 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations Brain, March 1, 2006; 129(3): 676 - 685. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
